These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 9637735)

  • 1. Reasoning enantioselectivity and kinetics of seleno-subtilisin from the subtilisin template.
    Häring D; Hubert B; Schüler E; Schreier P
    Arch Biochem Biophys; 1998 Jun; 354(2):263-9. PubMed ID: 9637735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subtilisin BPN' variants: increased hydrolytic activity on surface-bound substrates via decreased surface activity.
    Brode PF; Erwin CR; Rauch DS; Barnett BL; Armpriester JM; Wang ES; Rubingh DN
    Biochemistry; 1996 Mar; 35(10):3162-9. PubMed ID: 8605150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Semisynthetic Enzymes in Asymmetric Synthesis: Enantioselective Reduction of Racemic Hydroperoxides Catalyzed by Seleno-Subtilisin.
    Häring D; Schüler E; Adam W; Saha-Möller CR; Schreier P
    J Org Chem; 1999 Feb; 64(3):832-835. PubMed ID: 11674154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetic studies of the inhibitory effects of propeptides subtilisin BPN' and Carlsberg to bacterial serine proteases.
    Huang HW; Chen WC; Wu CY; Yu HC; Lin WY; Chen ST; Wang KT
    Protein Eng; 1997 Oct; 10(10):1227-33. PubMed ID: 9488148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic specificities of BPN' and Carlsberg subtilisins. Mapping the aromatic binding site.
    Karasaki Y; Ohno M
    J Biochem; 1978 Sep; 84(3):531-8. PubMed ID: 102640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonessential active site residues modulate selenosubtilisin's kinetic mechanism.
    Peterson EB; Hilvert D
    Biochemistry; 1995 May; 34(20):6616-20. PubMed ID: 7756293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refined crystal structure of the complex of subtilisin BPN' and Streptomyces subtilisin inhibitor at 1.8 A resolution.
    Takeuchi Y; Satow Y; Nakamura KT; Mitsui Y
    J Mol Biol; 1991 Sep; 221(1):309-25. PubMed ID: 1920411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new substrate and two inhibitors applicable for thermitase, subtilisin BPN' and alpha-chymotrypsin. Comparison of kinetic parameters with customary substrates and inhibitors.
    Brömme D; Fittkau S
    Biomed Biochim Acta; 1985; 44(7-8):1089-94. PubMed ID: 3910035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The refined crystal structure of subtilisin Carlsberg at 2.5 A resolution.
    Neidhart DJ; Petsko GA
    Protein Eng; 1988 Oct; 2(4):271-6. PubMed ID: 3150541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enantiocomplementary enzymatic resolution of the chiral auxiliary: cis,cis-6-(2,2-dimethylpropanamido)spiro[4.4]nonan-1-ol and the molecular basis for the high enantioselectivity of subtilisin Carlsberg.
    Mugford PF; Lait SM; Keay BA; Kazlauskas RJ
    Chembiochem; 2004 Jul; 5(7):980-7. PubMed ID: 15239056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineering substrate preference in subtilisin: structural and kinetic analysis of a specificity mutant.
    Ruan B; London V; Fisher KE; Gallagher DT; Bryan PN
    Biochemistry; 2008 Jun; 47(25):6628-36. PubMed ID: 18507395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering subtilisin BPN' for site-specific proteolysis.
    Carter P; Nilsson B; Burnier JP; Burdick D; Wells JA
    Proteins; 1989; 6(3):240-8. PubMed ID: 2516317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incorporation of a stabilizing Ca(2+)-binding loop into subtilisin BPN'.
    Braxton S; Wells JA
    Biochemistry; 1992 Sep; 31(34):7796-801. PubMed ID: 1510966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Designing subtilisin BPN' to cleave substrates containing dibasic residues.
    Ballinger MD; Tom J; Wells JA
    Biochemistry; 1995 Oct; 34(41):13312-9. PubMed ID: 7577915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical engineering of enzymes: altered catalytic activity, predictable selectivity and exceptional stability of the semisynthetic peroxidase seleno-subtilisin.
    Häring D; Schreier P
    Naturwissenschaften; 1999 Jul; 86(7):307-12. PubMed ID: 10451855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular enzymes: gene regulation and structure function relationship studies.
    Jarnagin AS; Ferrari E
    Biotechnology; 1992; 22():189-217. PubMed ID: 1504587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assignment of histidine resonances in the 1H NMR (500 MHz) spectrum of subtilisin BPN' using site-directed mutagenesis.
    Bycroft M; Fersht AR
    Biochemistry; 1988 Sep; 27(19):7390-4. PubMed ID: 3061456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunologic comparison of intracellular and extracellular serine proteases from Bacillus amyloliquefaciens and some other proteases].
    Shaginian KA; Shaginian LA; Ianonis VV; Strongin AIa; Stepanov BM
    Biokhimiia; 1981 Jul; 46(7):1290-7. PubMed ID: 6791708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in binding modes of enantiomers of 1-acetamido boronic acid based protease inhibitors: crystal structures of gamma-chymotrypsin and subtilisin Carlsberg complexes.
    Stoll VS; Eger BT; Hynes RC; Martichonok V; Jones JB; Pai EF
    Biochemistry; 1998 Jan; 37(2):451-62. PubMed ID: 9425066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active-site titration of serine proteases using a fluoride ion selective electrode and sulfonyl fluoride inhibitors.
    Hsia CY; Ganshaw G; Paech C; Murray CJ
    Anal Biochem; 1996 Nov; 242(2):221-7. PubMed ID: 8937565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.